Ameloblastoma
📧 Sign up to get email alerts when something new happens for Ameloblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: Virtual Lesion Segmentation and Mandibular Ameloblastoma Radiographic Safety Margin [NA]
A clinical trial is recruiting to evaluate virtual lesion segmentation and radiographic safety margins in mandibular ameloblastoma. The spon…
-
CLINICAL_TRIALS research · 2025-02-11Clinical Trial Update: Neoadjuvant Therapy With Conservative Surgery vs. Up-front Conservative Surgery for BRAF V600E-Mutated Ameloblastoma [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating neoadjuvant therapy followed by conservative surgery versus upfront conservative surgery for patien…
-
CLINICAL_TRIALS trial_result · 2025-01-06Clinical Trial Update: Effect of Tetracycline Socked Pack on Acceleration of Healing During Marsupialization [NA]
A completed clinical trial evaluating whether a tetracycline-soaked pack accelerates healing during marsupialization for ameloblastoma.
-
CLINICAL_TRIALS research · 2024-10-22Clinical Trial Update: Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma [Phase 2]
A Phase 2 neoadjuvant targeted therapy trial for ameloblastoma with BRAF V600E mutation is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma [Phase 3]
A Phase 3 trial exploring fenestration decompression combined with dalafenib for BRAF-mutant ameloblastoma is in unknown status.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma [Phase 2]
Phase 2 trial investigating dabrafenib and trametinib for BRAF-mutated ameloblastoma has completed with results posted in 2020.